KLK3 and neoplasm: Quantitative-PCR (Q-PCR) analysis in matched prostate normal/tumor tissues showed that decreased expression of PMEPA1 in approximately 65% of prostate tumors, which also strongly associated with higher pathologic stage and serum prostate-specific antigen (PSA) [13].